Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-13 · accession 0001396814-24-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | 2024-09-13 | PCRX | GAUGLER DARYL | COO | S - Sale | $12.86 | -500 | 115.7K | -0.4% | -$6,430 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-13 | S | D | 500 | $12.86 | 115,699.95 | D | — | — |